ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 132 filers reported holding ATEA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,734 | -19.8% | 4,578 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $17,122 | -27.8% | 4,578 | -7.1% | 0.00% | 0.0% |
| Q4 2022 | $23,704 | -15.5% | 4,928 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $28,040 | -19.9% | 4,928 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $34,989 | -1.7% | 4,928 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $35,580 | -78.9% | 4,928 | -73.9% | 0.00% | -50.0% |
| Q4 2021 | $168,707 | -74.5% | 18,871 | 0.0% | 0.00% | -80.0% |
| Q3 2021 | $661,617 | +131.9% | 18,871 | +308.4% | 0.01% | +150.0% |
| Q1 2021 | $285,347 | +40.9% | 4,621 | -4.7% | 0.00% | +33.3% |
| Q4 2020 | $202,508 | – | 4,847 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,637,331 | $57,405,000 | 37.04% |
| Bain Capital Life Sciences Investors, LLC | 3,700,000 | $129,722,000 | 8.05% |
| Cormorant Asset Management, LP | 4,928,756 | $172,802,000 | 7.02% |
| RA Capital Management | 5,427,655 | $190,294,000 | 2.64% |
| CM Management, LLC | 100,000 | $3,506,000 | 2.62% |
| Ghost Tree Capital, LLC | 150,000 | $5,259,000 | 1.54% |
| ORACLE INVESTMENT MANAGEMENT INC | 309,126 | $10,838,000 | 1.35% |
| Perceptive Advisors | 2,259,224 | $79,208,000 | 1.15% |
| Omega Fund Management, LLC | 164,577 | $5,770,000 | 0.65% |
| Monashee Investment Management LLC | 100,000 | $3,506,000 | 0.65% |